Loop Capital Lowers Tempus AI (NASDAQ:TEM) Price Target to $52.00

Tempus AI (NASDAQ:TEM) had its target price decreased by Loop Capital from $57.00 to $52.00 in a report issued on Tuesday morning,Benzinga reports. Loop Capital currently has a buy rating on the stock.

Several other analysts have also issued reports on the stock. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Piper Sandler reiterated a “neutral” rating and set a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Needham & Company LLC restated a “buy” rating and issued a $56.00 price objective on shares of Tempus AI in a research note on Tuesday. Bank of America boosted their price target on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Finally, Wolfe Research began coverage on Tempus AI in a research note on Friday, December 13th. They issued an “outperform” rating and a $60.00 price objective on the stock. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $56.36.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $34.75 on Tuesday. The stock’s 50-day simple moving average is $46.80 and its two-hundred day simple moving average is $47.09. Tempus AI has a 52-week low of $22.89 and a 52-week high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Insider Buying and Selling

In other Tempus AI news, COO Ryan Fukushima sold 20,000 shares of the business’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $39.61, for a total value of $792,200.00. Following the sale, the chief operating officer now owns 982,442 shares in the company, valued at $38,914,527.62. The trade was a 2.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the transaction, the insider now directly owns 16,164,449 shares of the company’s stock, valued at $694,263,084.55. This trade represents a 2.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 865,041 shares of company stock valued at $35,917,673.

Institutional Trading of Tempus AI

Several hedge funds have recently modified their holdings of TEM. WINTON GROUP Ltd purchased a new position in shares of Tempus AI in the second quarter valued at $634,000. Massachusetts Financial Services Co. MA bought a new position in Tempus AI during the second quarter valued at $28,246,000. Lingotto Investment Management LLP bought a new stake in shares of Tempus AI in the 2nd quarter worth about $32,685,000. Davidson Kempner Capital Management LP purchased a new stake in shares of Tempus AI during the 2nd quarter valued at about $2,271,000. Finally, Marshall Wace LLP bought a new position in shares of Tempus AI in the 2nd quarter valued at about $4,861,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.